10th Edition of the Ph. Eur.

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
The 10th Edition of the Ph. Eur. consists of new texts (amongst others, 5.25. Process Analytical Technology, PAT) as well as all current texts from the 9th Edition, some of which have been revised or corrected.
As of the 10th Edition of the Ph. Eur.,
- revised and / or corrected parts of texts are indicated by vertical lines (print version),
- horizontal lines indicate where parts of texts have been deleted (print version),
- a QR Code is included at the start of each text, providing a link to further information (e.g. the Knowledge database),
- the wording used in the calculation of percentage contents in tests for related substances has been modified to specify the full name of the substance (i.e. including counter-ions, hydrates etc.),
- tests using diphosphorus pentoxide, mainly tests for loss on drying, have been modified to avoid the use of this substance due to its toxicity,
- the names and descriptions of the reagents used to describe stationary GC phases have been revised,
- ‘Tamper-proof ’ has been replaced by ‘tamper-evident’,
- reference to general chapter 2.8.23. Microscopic examination of herbal drugs has been added when microscopic examination is carried out using a powder with a non-standard sieve size,
- the terms ‘coarse’ and ‘coarsely’ have been deleted from ‘coarse powder’ and ‘coarsely powdered herbal drug’ (2.9.12. Sieve test),
- results are expressed in per cent instead of per cent m/m in the tests 2.8.16 Dry residue of extracts and 2.8.17 Loss on drying of extracts.
The 10th edition of the Ph. Eur. will be released in July 2019 and will be updated with eight supplements over the next 3 years (10.1 to 10.8). The new and revised Texts of the 10th Edition will become official on 1 January 2020.
Related GMP News
23.06.2025Is Knowledge Management a Part of the Pharmaceutical Quality System?
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review